Lawrence W Fitzgerald

Title: The Innovative Contributions of Lawrence W. Fitzgerald

Introduction

Lawrence W. Fitzgerald is a notable inventor based in Milford, CT (US). He has made significant contributions to the field of biomedical research, particularly in the development of animal models for studying neurological disorders. His work has implications for understanding diseases that involve dopaminergic dysfunction.

Latest Patents

Fitzgerald holds a patent for a transgenic mouse model designed to study diseases involving dopaminergic dysfunction. The patent, titled "Transgenic mouse as model for diseases involving dopaminergic dysfunction," describes a transgenic mouse exhibiting a circling phenotype due to insertional mutagenesis. This innovative model was created by introducing genetic material into the mouse genome at an embryonic stage, which alters an endogenous genetic locus affecting motor function. The transgenic mouse line, designated TgX15, has been found to be a valuable resource for investigating the molecular genetic mechanisms that influence brain function and behavior. Additionally, these mice may be instrumental in evaluating new therapeutic agents for disorders such as Parkinsonism and schizophrenia.

Career Highlights

Fitzgerald is associated with Health Research, Inc., where he continues to contribute to advancements in medical research. His work has garnered attention for its potential to enhance our understanding of complex neurological conditions.

Collaborations

Fitzgerald has collaborated with notable colleagues, including Anil K. Ratty and John J. Mullins. These partnerships have further enriched his research endeavors and expanded the impact of his work in the scientific community.

Conclusion

Lawrence W. Fitzgerald's innovative work in developing transgenic mouse models has significant implications for understanding and treating neurological disorders. His contributions continue to advance the field of biomedical research and offer hope for new therapeutic strategies.